A detailed history of Albion Financial Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Albion Financial Group holds 45,218 shares of ABBV stock, worth $7.72 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
45,218
Previous 43,999 2.77%
Holding current value
$7.72 Million
Previous $8.69 Million 7.52%
% of portfolio
0.56%
Previous 0.61%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

BUY
$164.99 - $203.87 $201,122 - $248,517
1,219 Added 2.77%
45,218 $8.04 Million
Q3 2024

Oct 09, 2024

BUY
$163.84 - $199.33 $207,421 - $252,351
1,266 Added 2.96%
43,999 $8.69 Million
Q2 2024

Jul 10, 2024

BUY
$154.79 - $180.76 $27,552 - $32,175
178 Added 0.42%
42,733 $7.33 Million
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $4.81 Million - $5.49 Million
30,123 Added 242.3%
42,555 $7.75 Million
Q2 2023

Jul 25, 2023

SELL
$132.51 - $164.9 $1,457 - $1,813
-11 Reduced 0.09%
12,432 $1.67 Million
Q4 2022

Feb 03, 2023

SELL
$138.31 - $165.87 $35,407 - $42,462
-256 Reduced 2.02%
12,443 $2.01 Million
Q3 2022

Oct 27, 2022

SELL
$134.21 - $153.93 $13,152 - $15,085
-98 Reduced 0.77%
12,699 $1.7 Million
Q2 2022

Jul 29, 2022

SELL
$137.62 - $174.96 $68,810 - $87,480
-500 Reduced 3.76%
12,797 $1.96 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $331,797 - $411,667
-2,514 Reduced 15.9%
13,297 $2.16 Million
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $19,874 - $25,147
-185 Reduced 1.16%
15,811 $2.14 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $39,979 - $44,539
380 Added 2.43%
15,996 $1.8 Million
Q4 2020

Feb 19, 2021

BUY
$80.49 - $108.67 $88,941 - $120,080
1,105 Added 7.61%
15,616 $1.67 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $142,610 - $167,377
1,660 Added 12.92%
14,511 $1.27 Million
Q2 2020

Aug 17, 2020

BUY
$73.37 - $98.18 $368,684 - $493,354
5,025 Added 64.21%
12,851 $1.26 Million
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $163,765 - $248,288
2,539 Added 48.02%
7,826 $596,000
Q4 2019

Jan 31, 2020

BUY
$72.13 - $90.25 $13,921 - $17,418
193 Added 3.79%
5,287 $468,000
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $31,490 - $37,860
-500 Reduced 8.94%
5,094 $386,000
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $4,628 - $5,447
60 Added 1.08%
5,594 $451,000
Q2 2017

Aug 15, 2017

BUY
N/A
5,534
5,534 $401,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $302B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Albion Financial Group Portfolio

Follow Albion Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

News

Stay updated on Albion Financial Group with notifications on news.